Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma

Gastroenterology

Volumn 143, Issue 2, 2012, Pages

  Koch, Christine ^a   Paetzold, Sylvie ^a   Trojan, Joerg ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DACARBAZINE; GLYCOPROTEIN GP 100; IPILIMUMAB; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; COLONOSCOPY; DIARRHEA; ENTEROCOLITIS; FEVER; HUMAN; INTESTINE ULCER; LEUKOCYTOSIS; LUNG METASTASIS; LYMPHOCYTOPENIA; MALE; METASTATIC MELANOMA; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; VACCINATION;

EID: 84864245041     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.01.042     Document Type: Note

References (3)

1. F.S. Hodi, S.J. O'Day, D.F. McDermott Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 2010 711 723
2. C. Robert, L. Thomas, I. Bondarenko Ipilimumab plus dacarbazine for previously untreated metastatic melanoma N Engl J Med 364 2011 2517 2526
3. K.C. Kaehler, A. Hauschild Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma J Dtsch Dermatol Ges 9 2011 277 286